ReviewKidney cancer (Clifton, Va.)2017

Imaging Response of Antiangiogenic and Immune-Oncology Drugs in Metastatic Renal Cell Carcinoma (mRCC): Current Status and Future Challenges.

Laure Fournier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.